![Zhen Su](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Zhen Su
Directeur/Bestuurslid bij
KARYOPHARM THERAPEUTICS INC.
Vermogen: - $ op 31-05-2026
Profiel
Zhen Su is currently Chief Executive Officer & Director at Marengo Therapeutics, Inc. since 2021, Independent Director at Karyopharm Therapeutics, Inc. since 2023, and Independent Director at CytomX Therapeutics, Inc. since 2024.
Former roles include SVP & Global Head-Oncology Business at Merck KGaA from 2019 to 2021, Chief Medical Officer at EMD Serono, Inc. from 2017 to 2019, and Director-Cell & Gene Therapy Program at the University of Florida from 2006 to 2009.
Education includes an MBA from the University of Toronto and a doctorate from Dresden University of Technology.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-06-2026 | 0 ( -.--% ) | - $ | 31-05-2026 | |
| 30-03-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Zhen Su
| Bedrijven | Functie | Begin |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Directeur/Bestuurslid | 31-08-2023 |
| CYTOMX THERAPEUTICS, INC. | Directeur/Bestuurslid | 21-03-2024 |
Marengo Therapeutics, Inc.
 Marengo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies for cancer treatment | Algemeen Directeur | 01-07-2021 |
Eerdere bekende functies van Zhen Su
| Bedrijven | Functie | Einde |
|---|---|---|
| MERCK KGAA | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Hoofd Techniek/Wetenschap/O&O | 01-01-2019 |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-2009 |
Opleiding van Zhen Su
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
75
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Dresden University of Technology
 Dresden University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies for cancer treatment | Health Technology |
